Publications found:
54,468
Sort by:
Global PCR & Real-time PCR Molecular Diagnostics Market Size study, by Technology (Traditional PCR, Real-time PCR, Digital PCR), By Product (Instruments, Reagents and Consumables), By Application (Infectious Diseases Testing and Oncology Testing), By End-Users (Hospitals, Diagnostic Laboratories, Academic & Research Centers and Others) and Regional Forecasts 2020-2027
US$ 3,000.00
Global PCR & Real-time PCR Molecular Diagnostics Market is valued approximately USD 4.10 billion in 2019 and is anticipated to grow with a healthy growth rate of more than 4.00% over the forecast peri...
October 2020
200 pages
Global Breast Cancer Therapeutics Market Size study, By Product (Hormone Drugs, Chemotherapy Drugs, Targeted Drug Therapy), By Distribution Channel (Hospitals, Ambulatory Surgical Centers, Clinics, e-commerce, Retail Pharmacies), and Regional Forecasts 2020-2027
US$ 3,000.00
Global Breast Cancer Therapeutics Market is valued approximately at USD 19.57 billion in 2019 and is anticipated to grow with a healthy growth rate of more than 10.16% over the forecast period 2020-20...
October 2020
200 pages
2024 World Cancer Diagnostics Market: A 97-Country Analysis-Supplier Shares and Strategies, Volume and Sales Segment Forecasts for Major Tumor Markers, Emerging Technologies, Latest Instrumentation, Growth Opportunities
US$ 48,500.00
This new 97-country report from LeadingMarketResearch.com is available by region, country, market segment, section, or individual test. The report is available by section, and can be customized to spe...
October 2020
1515 pages
Immuno-Oncology Market, By Type [mAb (Naked, Conjugate), Cancer Vaccines, Immune Checkpoint Inhibitors (PD-1, PD-L1, CTLA-4]), By Application (Lung, Melanoma, Leukemia, Lymphoma) - Global Forecast to 2024
US$ 3,000.00
... to launch new and most effective therapies. According to the report “Immuno-Oncology Market, By Type [mAb (Naked, Conjugate), Cancer Vaccines, Immune Checkpoint Inhibitors (PD-1, PD-L1, CTLA-4]), By Application ...
October 2020
195 pages
Global Oncology Companion Diagnostic Market Size study, by Product & Service (Product and Services), by Technology (Polymerase Chain Reaction (PCR), Next-Generation Sequencing (NGS), Immunohistochemistry (IHC), In situ hybridization (ISH)/Fluorescence in situ hybridization (FISH) and Others), by Disease Type (Breast Cancer, Non-Small Cell Lung Cancer, Colorectal Cancer, Leukemia, Melanoma, Prostate Cancer and Others), by End User (Hospital, Pathology/Diagnostic Laboratory and Academic Medical Center) and Regional Forecasts 2020-2027
US$ 3,000.00
Global Oncology Companion Diagnostic Market is valued approximately at USD 2.2 billion in 2019 and is anticipated to grow with a healthy growth rate of more than 12.7% over the forecast period 2020-20...
October 2020
200 pages
